Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study

被引:15
作者
Chamnan, P. [1 ]
Simmons, R. K. [1 ]
Khaw, K. T. [2 ]
Wareham, N. J. [1 ]
Griffin, S. J. [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit,Sch Clin Med, Cambridge CB2 0QQ, England
[2] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit, Cambridge CB2 0QQ, England
基金
英国医学研究理事会;
关键词
modelling study; population impact; prestratification; risk scores; screening; Type; 2; diabetes; IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTIONS; COST-EFFECTIVENESS; CARDIOVASCULAR RISK; PEOPLE; SCORE; CANCER; PREVENTION; PROGRAM; QUESTIONNAIRE;
D O I
10.1111/j.1464-5491.2012.03609.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabet. Med. 29, 893904 (2012) Abstract Background Diabetes risk assessment has been proposed as part of the National Health Service Health Checks programme, and HbA1c has recently been recommended as a diagnostic test for diabetes at a threshold of 48 mmol/mol (6.5%). We estimated the potential population impact of different stepwise screening strategies to identify individuals at high risk who might be offered preventive interventions. Methods Using data from 5910 participants in the European Prospective Investigation of Cancer (EPIC)-Norfolk cohort with HbA1c measurements, we modelled different stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes using different HbA1c cut-off points with and without a stage of prestratification. For each strategy, we estimated the number needed to have a diagnostic test, the number needed to treat to prevent one new case of Type 2 diabetes, and the number of new cases that could be prevented in the population over 3 years. Relative risk reductions for estimated effects of intensive lifestyle intervention were derived from the US Diabetes Prevention Program. Results Compared with inviting all individuals in an average primary care trust for a diagnostic test, a stepwise screening approach using simple routine data such as age and anthropometric indices could prevent a slightly lower number (lower-upper estimates) of new cases of Type 2 diabetes over 3 years (224 [130359] and 193 [109315] cases respectively) but would only require half the population to be invited for a diagnostic blood test. A total of 162 (88274) cases could be prevented by inviting individuals with a Cambridge risk score of = 0.15, with only 40% of the total population requiring diagnostic blood tests. Using a participant completed questionnaire for risk assessment (FINDRISC) was less effective, mainly relating to the questionnaire response rate. Providing preventive interventions to those with a lower HbA1c of 37< 48 mmol/mol (5.5< 6.5%) could prevent more cases but with a disproportionately higher workload, compared with using the recommended HbA1c threshold of 42< 48 mmol/mol (6.0< 6.5%). Conclusions Compared with mass screening, an approach using routine data for risk stratification followed by an HbA1c test with a threshold of 42< 48 mmol/mol (6.0< 6.5%) for identifying individuals suitable for preventive interventions might prevent slightly fewer cases of Type 2 diabetes but with potential cost-savings.
引用
收藏
页码:893 / 904
页数:12
相关论文
共 48 条
  • [2] [Anonymous], GUID METH TECHN APPR
  • [3] [Anonymous], HDB VASC RISK ASS RI
  • [4] [Anonymous], 2008, PUTT PREV 1 VASC CHE
  • [5] Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study
    Chamnan, Parinya
    Simmons, Rebecca K.
    Khaw, Kay-Tee
    Wareham, Nicholas J.
    Griffin, Simon J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 : 1016
  • [6] Incidence of Type 2 Diabetes Using Proposed HbA1c Diagnostic Criteria in the European Prospective Investigation of Cancer-Norfolk Cohort Implications for preventive strategies
    Chamnan, Parinya
    Simmons, Rebecca K.
    Forouhi, Nita G.
    Luben, Robert N.
    Khaw, Kay-Tee
    Wareham, Nicholas J.
    Griffin, Simon J.
    [J]. DIABETES CARE, 2011, 34 (04) : 950 - 956
  • [7] Screening for type 2 diabetes and impaired glucose metabolism
    Colagiuri, S
    Hussain, Z
    Zimmet, P
    Cameron, A
    Shaw, J
    [J]. DIABETES CARE, 2004, 27 (02) : 367 - 371
  • [8] Day N, 1999, BRIT J CANCER, V80, P95
  • [9] Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial
    Eborall, Helen C.
    Griffin, Simon J.
    Prevost, A. Toby
    Kinmonth, Ann-Louise
    French, David P.
    Sutton, Stephen
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7618): : 486 - 489
  • [10] Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes
    Eddy, DM
    Schlessinger, L
    Kahn, R
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (04) : 251 - 264